Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts (TMCI) posted Total Non-Current Liabilities of $103.9 million for Q1 2026, up 0.72% on a QoQ basis from $103.1 million in Q4 2025, and up 3.38% year-over-year from $100.5 million in Q1 2025.
Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $103.9 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 3.38% year-over-year to $103.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.9 million (up 3.38% YoY) and the FY2025 annual result came in at $103.1 million, down 1.01% from the prior year.
- Total Non-Current Liabilities was $103.9 million for Q1 2026 at Treace Medical Concepts, up from $103.1 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $116.3 million in Q1 2024 and bottomed at $59.6 million in Q1 2022.
- A 5-year average of $100.7 million and a median of $103.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 135.5% — and 2025, when it dropped 13.61%.
- Treace Medical Concepts' Total Non-Current Liabilities stood at $98.5 million in 2022, then gained by 15.66% to $113.9 million in 2023, then dropped by 8.56% to $104.2 million in 2024, then declined by 1.01% to $103.1 million in 2025, then advanced by 0.72% to $103.9 million in 2026.
- Business Quant data shows TMCI's Total Non-Current Liabilities at $103.9 million in Q1 2026, $103.1 million in Q4 2025, and $107.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 103.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.86 Mn |
| Dec 31, 2025 | 103.12 Mn |
| Sep 30, 2025 | 107.21 Mn |
| Jun 30, 2025 | 108.67 Mn |
| Mar 31, 2025 | 100.47 Mn |
| Dec 31, 2024 | 104.17 Mn |
| Sep 30, 2024 | 107.98 Mn |
| Jun 30, 2024 | 113.82 Mn |
| Mar 31, 2024 | 116.30 Mn |
| Dec 31, 2023 | 113.92 Mn |
| Sep 30, 2023 | 102.46 Mn |
| Jun 30, 2023 | 99.65 Mn |
| Mar 31, 2023 | 91.53 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 94.24 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 59.61 Mn |
| Dec 31, 2021 | 47.58 Mn |
| Sep 30, 2021 | 40.02 Mn |
| Jun 30, 2021 | 39.14 Mn |